Serum level of eight cytokines in Han Chinese patients with systemic lupus erythematosus using multiplex fluorescent microsphere method

Central European Journal of Immunology

Volumn 39, Issue 2, 2014, Pages 228-235

  Yin, Zhihua ^a   Huang, Jinxian ^a,b   He, Weizhen ^a   Cao, Zhijun ^a   Luo, Xiuxia ^a   Zhang, Chunrong ^a   Ye, Zhizhong ^a  

^a GUANGDONG MEDICAL UNIVERSITY   (China)

^b THE UNIVERSITY OF HONG KONG SHENZHEN HOSPITAL   (China)

Author keywords

Cytokine; Han Chinese; Systemic lupus erythematosus

Indexed keywords

ACETYLCYSTEINE; ALPHA2 INTERFERON; BIOLOGICAL MARKER; C REACTIVE PROTEIN; COMPLEMENT COMPONENT C3; CYTOKINE; DOUBLE STRANDED DNA ANTIBODY; GAMMA INTERFERON; GAMMA INTERFERON INDUCIBLE PROTEIN 10; INTERLEUKIN 17; INTERLEUKIN 6; INTERLEUKIN 8; NUCLEOSOME ANTIBODY; TUMOR NECROSIS FACTOR ALPHA;

ADULT; ARTICLE; BLOOD LEVEL; CONTROLLED STUDY; DISEASE ACTIVITY; ERYTHROCYTE SEDIMENTATION RATE; FEMALE; FLUORESCENCE; HAN CHINESE; HUMAN; MAJOR CLINICAL STUDY; MALE; MEASUREMENT; MULTIPLEX FLUORESCENT MICROSPHERE METHOD; PROTEIN EXPRESSION; PROTEINURIA; SYSTEMIC LUPUS ERYTHEMATOSUS;

EID: 84904510408     PISSN: 14263912     EISSN: 16444124     Source Type: Journal    
DOI: 10.5114/ceji.2014.43728     Document Type: Article

References (37)

1. Fu Q, Chen X, Cui H, et al. (2008): Association of elevated transcript levels of interferon-inducible chemokines with disease activity and organ damage in systemic lupus erythematosus patients. Arthritis Res Ther 10:R112.
2. Su DL, Lu ZM, Shen MN, et al. (2012): Roles of pro- and anti-inflammatory cytokines in the pathogenesis of SLE. J Biomed Biotechnol 2012: 347141.
3. Bombardier C, Gladman DD, Urowitz MB, et al. (1992): Derivation of the SLEDAI. A disease activity index for lupus patients. The Committee on Prognosis Studies in SLE. Arthritis Rheum 35: 630-640.
4. de Jager W, te Velthuis H, Prakken BJ, et al. (2003): Simultaneous detection of 15 human cytokines in single sample of stimulated peripheral blood mononuclear cells. Clin Diagn Lab Immunol 10: 133-139. (Pubitemid 36133841)
5. Fragoso-Loyo H, Richaud-Patin Y, Orozco-Narváez A, et al. (2007): Interleukin-6 and chemokines in the neuropsychiatric manifestations of systemic lupus erythematosus. Arthritis Rheum 56: 1242-1250. (Pubitemid 46608649)
6. Okamoto H, Iikuni N, Kamitsuji S, et al. (2006): IP-10/MCP-1 ratio in CSF is a useful diagnostic marker of neuropsychiatric lupus patients. Rheumatology (Oxford) 45: 232-234. (Pubitemid 43160094)
7. Fragoso-Loyo H, Atisha-Fregoso Y, Llorente L, et al. (2013): Inflammatory profile in cerebrospinal fluid of patients with headache as a manifestation of neuropsychiatric systemic lupus erythematosus. Rheumatology (Oxford) [Epub ahead of print].
8. Carneiro JR, Fuzii HT, Kayser C, et al. (2011): IL-2, IL-5, TNF-α and IFN-γ mRNA expression in epidermal keratinocytes of systemic lupus erythematosus skin lesions. Clinics (Sao Paulo) 66: 77-82.
9. Arora V, Verma J, Marwah V, et al. (2012): Cytokine imbalance in systemic lupus erythematosus: a study on northern Indian subjects. Lupus 21: 596-603.
10. Park YB, Lee SK, Kim DS, et al. (1998): Elevated interleukin-10 levels correlated with disease activity in systemic lupus erythematosus. Clin Exp Rheumatol 16: 283-288. (Pubitemid 28219167)
11. Houssiau FA, Lefebvre C, Vanden Berghe M, et al. (1995): Serum interleukin 10 titers in systemic lupus erythematosus reflect disease activity. Lupus 4: 393-395.
12. Koenig KF, Groeschl I, Pesickova SS, et al (2012): Serum cytokine profile in patients with active lupus nephritis. Cytokine 60: 410-416.
13. Chun HY, Chung JW, Kim HA, et al. (2007): Cytokine IL-6 and IL-10 as biomarkers in systemic lupus erythematosus. J Clin Immunol 27: 461-466.
14. Gómez D1, Correa PA, Gómez LM, et al. (2004):Th1/Th2 cytokines in patients with systemic lupus erythematosus: is tumor necrosis factor alpha protective? Semin Arthritis Rheum 33: 404-413.
15. Kim T, Kanayama Y, Negoro N, et al. (1987): Serum levels of interferons in patients with systemic lupus erythematosus. Clin Exp Immunol 70: 562-569. (Pubitemid 18013195)
16. Al-Janadi M, Al-Balla S, Al-Dalaan A, et al. (1993): Cytokine profile in systemic lupus erythematosus, rheumatoid arthritis, and other rheumatic diseases. J Clin Immunol 13: 58-67. (Pubitemid 23047997)
17. Tokano Y, Morimoto S, Kaneko H, et al. (1999): Levels of IL-12 in the sera of patients with systemic lupus erythematosus (SLE) - relation to Th1- and Th2-derived cytokines. Clin Exp Immunol 116: 169-173. (Pubitemid 29170021)
18. Robak E, Smolewski P, Wozniacka A, et al. (2004): Relationship between peripheral blood dendritic cells and cytokines involved in the pathogenesis of systemic lupus erythematosus. Eur Cytokine Netw 15: 222-230. (Pubitemid 39389919)
19. Davas EM, Tsirogianni A, Kappou I, et al. (1999): Serum IL-6, TNFa, p55 srTNFa, p75 srTNFa, srIL- 2a levels and disease activity in systemic lupus erythematosus. Clin Rheumatol 18: 17-22. (Pubitemid 29104747)
20. Mahmoud RA1, El-Gendi HI, Ahmed HH. (2005): Serum neopterin, tumor necrosis factor-alpha and soluble tumor necrosis factor receptor II (p75) levels and disease activity in Egyptian female patients with systemic lupus erythematosus. Clin Biochem 38: 134-141.
21. Sabry A, Sheashaa H, El-Husseini A, et al. (2006): Proinflammatory cytokines (TNF-alpha and IL-6) in Egyptian patients with SLE: its correlation with disease activity. Cytokine 35: 148-153. (Pubitemid 44666430)
22. Swadzba J, Iwaniec T, Musial J (2011): Increased level of tumor necrosis factor-α in patients with antiphospholipid syndrome: marker not only of inflammation but also of the prothrombotic state. Rheumatol Int 31: 307-313.
23. Lacki JK, Leszczynski P, Kelemen J, et al. (1997): Cytokine concentration in serum of lupus erythematosus patients: the effect on acute phase response. J Med 28: 99-107. (Pubitemid 27306337)
24. Viallard JF, Pellegrin JL, Ranchin V, et al. (1999): Th1 (IL-2, interferon-gamma (IFN-gamma)) and Th2 (IL-10, IL-4) cytokine production by peripheral blood mononuclear cells (PBMC) from patients with systemic lupus erythematosus (SLE). Clin Exp Immunol: 115: 189-195. (Pubitemid 29030384)
25. Chang DM, Su WL, Chu SJ (2002): The expression and significance of intracellular T helper cytokines in systemic lupus erythematosus. Immunol Invest 31: 1-12. (Pubitemid 34311280)
26. Brugos B, Vincze Z, Sipka S, et al. (2012): Serum and urinary cytokine levels of SLE patients. Pharmazie 67: 411-413.
27. Koenig KF, Groeschl I, Pesickova SS, et al. (2012): Serum cytokine profile in patients with active lupus nephritis. Cytokine 60: 410-416.
28. McCarthy EM, Smith S, Lee RZ, et al. (2014): The association of cytokines with disease activity and damage scores in systemic lupus erythematosus patients. Rheumatology (Oxford) [Epub ahead of print].
29. Ishida H, Muchamuel T, Sakaguchi S, et al. (1994): Continuous administration of anti-interleukin 10 antibodies delays onset of autoimmunity in NZB/W F1 mice. J Exp Med 179: 305-310. (Pubitemid 24012996)
30. Ravirajan CT, Wang Y, Matis LA, et al. (2004): Effect of neutralizing antibodies to IL-10 and C5 on the renal damage caused by a pathogenic human anti-dsDNA antibody. Rheumatology (Oxford) 43: 442-447. (Pubitemid 38489360)
31. Nielepkowicz-Goździńska A, Fendler W, Robak E, et al. (2013): Exhaled cytokines in systemic lupus erythematosus with lung involvement. Pol Arch Med Wewn 123: 141-148.
32. Yung S, Cheung KF, Zhang Q, et al. (2013): Mediators of inflammation and their effect on resident renal cells: implications in lupus nephritis. Clin Dev Immunol 2013: 317682.
33. Vincent FB, Northcott M, Hoi A, et al. (2013): Clinical associations of serum interleukin-17 in systemic lupus erythematosus. Arthritis Res Ther 15: R97.
34. Ambrosi A, Espinosa A, Wahren-Herlenius M (2012): IL-17: a new actor in IFN-driven systemic autoimmune diseases. Eur J Immunol 42: 2274-2284.
35. Chen DY, Chen YM, Wen MC, et al. (2012): The potential role of Th17 cells and Th17-related cytokines in the pathogenesis of lupus nephritis. Lupus 21: 1385-1396.
36. Okamoto H, Iikuni N, Kamitsuji S, et al. (2006): IP-10/MCP-1 ratio in CSF is an useful diagnostic marker of neuropsychiatric lupus patients. Rheumatology (Oxford) 45: 232-234. (Pubitemid 43160094)
37. Kong KO, Tan AW, Thong BY, et al. (2009): Enhanced expression of interferon-inducible protein-10 correlates with disease activity and clinical manifestations in systemic lupus erythematosus. Clin Exp Immunol 156: 134-140.